Related Experiment Video
Updated: Jul 11, 2025

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Systemic lupus erythematosus in pediatric patients: Pulmonary manifestations
Jonathan G Palafox-Flores1, Omar E Valencia-Ledezma2, Guillermo Vargas-López3
1Pediatric Pneumology Unit, Hospital Regional de Alta Especialidad de Ixtapaluca, Mexico.
Insights
Pulmonary manifestations in pediatric Systemic Lupus Erythematosus (SLE) are diverse, with pleurisy being most common. This study clarifies these lung issues in children, improving understanding beyond adult data.
Area of Science:
- Pediatric Rheumatology
- Pulmonology
- Systemic Lupus Erythematosus (SLE)
Background:
- Pulmonary involvement in pediatric Systemic Lupus Erythematosus (SLE) is understudied.
- Adult SLE pulmonary manifestations are often inaccurately extrapolated to pediatric cases.
- Limited data exists on the specific spectrum of lung diseases in children with SLE.
Purpose of the Study:
- To identify and characterize pulmonary manifestations in pediatric patients with SLE.
- To analyze associated symptoms and antibody levels in this population.
- To provide a clearer understanding of SLE's impact on pediatric lungs.
Main Methods:
- Retrospective review of 228 patient files from Hospital Regional de Alta Especialidad de Ixtapaluca.
- Identification of pulmonary manifestations, symptoms, and antibody levels.
- Statistical analysis using Chi-square and Mann-Whitney U tests for group comparisons.
Main Results:
- Pleurisy (14%) was the most frequent pulmonary manifestation.
- Other identified manifestations included pulmonary hemorrhage (3.9%) and thromboembolism (0.9%).
- Dyspnea (9.6%) was the primary symptom; pleural effusion was common in radiographic findings. No significant antibody level differences were noted between groups.
Conclusions:
- Pleurisy is the predominant pulmonary manifestation in pediatric SLE patients.
- The spectrum of pulmonary involvement in pediatric SLE is broad and varied.
- Further research is needed to fully elucidate the diverse presentations and management of lung disease in pediatric SLE.
Abstract:
The pulmonary manifestations of Systemic Lupus Erythematosus (SLE) in pediatric patients are poorly understood and the pulmonary manifestations reported from the adult population are generally extrapolated to the pediatric population. In the present work, the review of 228 files was carried out, in which the pulmonary manifestations, symptoms and antibody levels of the patients treated at the Hospital Regional de Alta Especialidad de Ixtapaluca (HRAEI), State of Mexico, Mexico, were identified. Statistical significance between groups was estimated using the Chi-square and Mann-Whitney U test. The main pulmonary manifestations identified were pleurisy (14 %), pulmonary hemorrhage (3.9 %), pulmonary thromboembolism (0.9 %), acute lupus pneumonitis (0.4 %), pulmonary arterial hypertension (0.4 %), and small lung syndrome (0.4 %). While the initial symptomatology was dyspnea with an incidence of 9.6 %, the mean oxygen saturation in the population was 96.87 %. Pleural effusion was identified as the most frequent pulmonary manifestation in radiographic changes. No statistically significant difference was found in antibody levels when comparing the groups. The most common pulmonary manifestation associated with SLE is pleurisy, however, the range of pulmonary manifestations in this type of patient can be very varied, as well as the presentation of each of them.
Related Concept Videos
Other Pulmonary Disorders
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pulmonary Embolism I: Introduction
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Cycle: Exhalation
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

